Helen G Durkin

Title: Innovations and Contributions of Helen G Durkin

Introduction

Helen G Durkin is a notable inventor based in Manhasset, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address health issues related to immunology. With a total of four patents to her name, her work has had a meaningful impact on medical science.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Mono, di and tri cyclic compounds useful for lowering IgE concentrations." This invention focuses on novel compounds that are derivatives of minocycline or doxycycline. The pharmaceutical compositions derived from these compounds are designed to lower excess IgE levels in mammals suffering from diseases where IgE is pathogenic. Another significant patent is "Methods for detecting parvovirus infections," which provides a method for diagnosing subjects with pathological conditions characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies.

Career Highlights

Helen G Durkin is affiliated with the State University of New York, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Some of her notable coworkers include Tamar A Smith-Norowitz and Martin Heath Bluth, who have collaborated with her on various projects and research initiatives.

Conclusion

Helen G Durkin's innovative contributions to the field of pharmaceuticals highlight her dedication to improving health outcomes through scientific research. Her patents reflect her commitment to addressing critical health issues, making her a significant figure in the realm of medical inventions.